Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients
Elke Jäger(Krankenhaus Nordwest), Alexander Knuth(National Center for Cancer Care and Research), Danila Valmori(Centre National de la Recherche Scientifique), Armin Bender(Georg Speyer Haus), Antje Neumann(Krankenhaus Nordwest), Herbert F. Oettgen, Gerd Ritter(Memorial Sloan Kettering Cancer Center), Erika Ritter(Ludwig Cancer Research), Dennis Panicali(Fox Chase Cancer Center), Sacha Gnjatic(Tisch Hospital), Maha Ayyoub(Inserm), Lloyd J. Old(Gynecologic Oncology Group), Julia Karbach(Memorial Sloan Kettering Cancer Center), Dirk Jäger(German Cancer Research Center), Linda Pan(Memorial Sloan Kettering Cancer Center), Eric W. Hoffman(Cornell University)
Cited by 217
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
|Journal of Clinical Oncology|2000|2.3k
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
|New England Journal of Medicine|2012|2.1k